Cart (0 Items)
Your cart is currently empty.
View ProductsTibulizumab Biosimilar – Anti-IL17A, TNFSF13B, CD257 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Tibulizumab Biosimilar - Anti-IL17A, TNFSF13B, CD257 mAb - Research Grade |
|---|---|
| Source | CAS 1849636-24-3 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Tibulizumab,LY 3090106,LY-3090106,LY3090106,IL17A, TNFSF13B, CD257,anti-IL17A, TNFSF13B, CD257 |
| Reference | PX-TA1494 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa-[scFv]2 |
| Clonality | Monoclonal Antibody |
Tibulizumab Biosimilar - Anti-IL17A, TNFSF13B, CD257 mAb binds to IL17A, C-His, recombinant protein in indirect ELISA Assay
Immobilized IL17A, C-His, recombinant protein (cat. No.PX-P5780) at 0.5µg/mL (100µL/well) can bind to Tibulizumab Biosimilar - Anti-IL17A, TNFSF13B, CD257 mAb (cat. No.PX-TA1494) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Antigen
Interleukin-17A(IL17A)
PX-P4824 210€
Antigen
IL17A, C-His, recombinant protein
PX-P5780 385€
Antigen
CD257 Recombinant Protein
PX-P4112 406€
Antigen
CD257 / BAFF / TNFSF13B, C-His, recombinant protein
PX-P5600 385€
SIL
Stable Isotope Labelled Tibulizumab Biosimilar – Anti-IL17A/TNFSF13B/CD257 mAb – Research Grade
PX-TA1494-SIL 15000€
ELISA
Reviews
Il n’y a pas encore d’avis.